Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 14

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 14
---
, if approved; |

| ● | the rate and degree of market acceptance of CER-1236 and any other product candidates we may develop, as well as the pricing and reimbursement of CER-1236 and any other product candidates we may develop, if approved; |

| ● | our expectations regarding our ability to obtain, maintain, protect and enforce intellectual property protection for CER-1236 and for any other product candidate; |

| ● | our ability to operate our business without infringing, misappropriating or otherwise violating the intellectual property rights of third parties; |

| ● | our ability to realize the anticipated benefits of any strategic transactions; |

| ● | our ability to attract and retain the continued service of our key personnel and to identify, hire, and then retain additional qualified personnel and our ability to attract additional collaborators with development, regulatory and commercialization expertise; |

| ● | our ability to maintain proper and effective internal controls; |

| ● | the ability to obtain or maintain the listing of our common stock, and our public warrants on Nasdaq; |

| ● | the impact of macroeconomic conditions and geopolitical turmoil on our                                                                     
 business and operations, including interest rates, inflationary pressures, capital market                                                  
 disruptions, changes in governmental agencies, international tariffs, trade protection measures, economic sanctions and economic slowdowns 
 or recessions;                                                                                                                             |

| ● | our expectations regarding the period during which we will qualify as an emerging growth company under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and as a smaller reporting company under the federal securities laws; and |

| ● | our anticipated use of our existing cash, cash equivalents and marketable securities. |

We have based these forward-looking statements largely on our current expectations and projections about our business, the industry in which we operate and financial trends that we believe may affect our business, financial condition, results of operations and prospects, and these forward-looking statements are not guarantees of future performance or development. These forward-looking statements speak only as of the date of this prospectus and are subject to a number of risks, uncertainties and assumptions described in “ Risk Factors” and elsewhere in this prospectus. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements